selected publications
- Unlocking the therapeutic potential of rigosertib as a selective therapy for ovarian cancer. Cell reports. Medicine. 2025 Academic Article GET IT
- Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer. Clinical and translational medicine. 2025 Academic Article GET IT
- PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth. Cancer research. 2022 Editorial Article GET IT
- Circling back to PTEN: Fumarate inhibits canonical tumor suppressor. Molecular cell. 2022 Comment GET IT
-
Patient-Derived In Vitro and In Vivo Models of Cancer.
Advances in experimental medicine and biology.
2022
Academic Article
GET IT
Times cited: 6